NuVasive | NUVA - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
AtriCure USD 1.97B 215M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 141.35B 3.31B 2025-12
Cooper Companies USD 15.95B 2.05B 2025-12
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 49.47B 3.81B 2025-12
Globus Medical USD 11.69B 3.95B 2025-12
Haemonetics USD 3.76B 1.44B 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 162.56B 38.21B 2026-04
J&J USD 561.65B 17.5B 2026-04
Merit Medical Systems USD 5.23B 297M 2025-12
Orthofix International USD 604M 25M 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12